Adagene Inc., a clinical-stage biotech company specializing in antibody-based cancer immunotherapies, announced that its CEO and President of R&D, Dr. Peter Luo, will participate in a fireside chat at the H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference on October 15, 2026. The event highlights Adagene's innovative SAFEbody® technology, designed to improve the safety and targeting of antibody therapies in cancer treatment. Adagene's lead clinical program, muzastotug (ADG126), is currently in advanced clinical trials for metastatic colorectal cancer, showcasing the company's progress in immunotherapy development. Investors can access the webcast on Adagene's website for 30 days post-conference.
Adagene's participation in the H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference is noted here with Pluang's health sector market data as of Oct 14, 2026 19:01 WIB. Of 150 priced health-sector US stocks tradable on Pluang, 105 rose and 40 fell today. Notable movers include ENVB at USD 1.34 with a -4.29% change, CLPT at USD 10.14 with a +3.36% and 100% buy order activity, and GH at USD 158.20 with a -2.40% change and a typical hold time of 3 days.
Genesis Global won the Best AI Solution for Software Development award at the 2026 AI in Capital Markets Awards for its product Genesis Create. This software combines AI with reusable components and financial expertise to help firms develop productio...
nuVizz has been recognized as an Accelerator in the 2026 Nucleus Research Transportation Management Value Matrix for its specialized last-mile delivery technology. The platform excels in coordinating complex delivery networks involving private fleets...
ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...
Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...
Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...
